Innovotech Inc. (TSXV:IOT)

Market Cap	12.96M
Revenue (ttm)	3.04M
Net Income (ttm)	392.16K
Shares Out	49.86M
EPS (ttm)	0.01
PE Ratio	34.73
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	75,500
Average Volume	39,395
Open	0.2200
Previous Close	0.2500
Day's Range	0.2200 - 0.2400
52-Week Range	0.0800 - 0.2800
Beta	1.00
RSI	59.61
Earnings Date	Aug 22, 2025

About Innovotech

Innovotech Inc. provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; and MBEC Assay kit, a screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms; pre-coated MBEC Assay lids; and order biofilm assays. It also provides antimicrobial contract research and antimicrobial testing; antimicrobial and anti-biofilm agents; an...

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Craig Milne
• Employees: 16
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: IOT